Forgive the new thread but it might be time to have a dedicated place for those Analyst snapshots that members post and are generally quite informative, but also Finance and even News media relating to Neuren's progress and prospects. The aim is to have a collation rather than scanning multiple threads as pieces get placed here or there.
Here's one, it might have been posted elsewhere:
https://unauthorised investment advice/health/neurens-stock-price-doubles-on-groundbreaking-drug-trial-ceo-says-its-just-getting-started/
Forgive the new thread but it might be time to have a dedicated...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.31 |
Change
-0.790(3.93%) |
Mkt cap ! $2.465B | |||
| Open | High | Low | Value | Volume |
| $19.86 | $19.99 | $17.97 | $22.67M | 1.196M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2222 | $19.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.31 | 8162 | 3 |
View Market Depth
| Last trade - 16.10pm 09/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$19.25 |
Change
-0.790 ( 4.18 %) |
||||
| Open | High | Low | Volume | ||
| $19.88 | $19.88 | $17.97 | 249066 | ||
| Last updated 15.59pm 09/05/2024 ? | |||||
| NEU (ASX) Chart |